X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

NTRK Fusion Gene Positive Advanced Solid TumorCompanies

This report lists the top NTRK Fusion Gene Positive Advanced Solid Tumor companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the NTRK Fusion Gene Positive Advanced Solid Tumor industry.

NTRK Fusion Gene Positive Advanced Solid TumorTop Companies

  1. Bayer

  2. Empire Genomics

  3. Roche

  4. NeoGenomics Laboratories

  5. OncoDNA

*Disclaimer: Top companies sorted in no particular order

 NTRK Fusion Gene Positive Advanced Solid Tumor Market Major Players

NTRK Fusion Gene Positive Advanced Solid TumorMarket Concentration

NTRK Fusion Gene Positive Advanced Solid TumorMarket Concentration

NTRK Fusion Gene Positive Advanced Solid TumorCompany List

  • Bayer AG

  • Teva Pharmaceuticals

  • Empire Genomics, LLC.

  • SeraCare Life Sciences

  • F. Hoffmann-La Roche Ltd

  • NeoGenomics Laboratories, Inc.

  • OncoDNA


Specific to NTRK Fusion Gene Positive Advanced Solid Tumor Market
Need More Details On Market Players And Competitors?
Download PDF

NTRK Fusion Gene Positive Advanced Solid Tumor Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)